Applicants,Chemical_Name,Funding_requested_for,Pharmaceutical,Priority_List,Schedules,Therapeutic_group
"Janssen, JANSSEN NZ LIMITED",Apalutamide,"Prostate cancer ,  non-metastatic, castration-resistant, high risk",Apalutamide,Options for investment,Community and Hospital,Oncology Agents and Immunosuppressants
